Compare NEXT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEXT | LMAT |
|---|---|---|
| Founded | 2010 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2014 | 2006 |
| Metric | NEXT | LMAT |
|---|---|---|
| Price | $7.86 | $94.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $8.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 3.1M | 238.5K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ N/A | $139.21 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $4.75 | $79.01 |
| 52 Week High | $12.12 | $118.01 |
| Indicator | NEXT | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 46.46 | 33.34 |
| Support Level | $6.53 | $82.65 |
| Resistance Level | $9.15 | $99.95 |
| Average True Range (ATR) | 0.42 | 3.72 |
| MACD | -0.11 | -0.58 |
| Stochastic Oscillator | 16.57 | 11.56 |
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.